Now in his 80s, Dr. Ruey J. Yu continues to work in the lab every day, hunting for biomarkers that could be used for early diagnosis of Alzheimer’s and other diseases. In 2016, Dr. Yu and Dr. Van Scott sold NeoStrata to Johnson & Johnson, which is expanding the company’s research labs into a centre of excellence for dermatological research.